Switch to:
Sanofi (NYSE:SNY)
Cash Flow for Capital Expenditures
$-5,663 Mil (TTM As of Dec. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Sanofi's cash flow for capital expenditures for the three months ended in Dec. 2014 was $-1,920 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2014 was $-5,663 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Sanofi Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Dec. 2014 was -960.422163588 (Jun. 2013 ) + -1917.69547325 (Dec. 2013 ) + -865.489130435 (Jun. 2014 ) + -1919.85203453 (Dec. 2014 ) = $-5,663 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Cash Flow_CPEX -1,355-1,921-2,344-2,170-2,602-2,081-2,345-2,115-1,918-1,920

Sanofi Quarterly Data

Jun10Dec10Jun11Dec11Jun12Dec12Jun13Dec13Jun14Dec14
Cash Flow_CPEX -842-2,081-1,199-2,345-986-2,115-960-1,918-865-1,920
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK